Cargando…

Evaluation of minocycline combined with favipiravir therapy in coronavirus disease 2019 patients: A case-series study

The aim of this study was to investigate the efficacy and safety of minocycline (MIN) and favipiravir combination therapy in patients with coronavirus disease 2019 (COVID-19) admitted to our hospital in Fukui Prefecture, Japan, in March and April of 2020. In this retrospective study, a favipiravir m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itoh, Kazuhiro, Sakamaki, Ippei, Hirota, Tomoya, Iwasaki, Hiromichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486618/ https://www.ncbi.nlm.nih.gov/pubmed/34627706 http://dx.doi.org/10.1016/j.jiac.2021.09.016

Ejemplares similares

Frequency and Risk Factors for Persistent and Concomitant Symptoms after Hospital Discharge for Coronavirus Disease 2019 in the Pre-omicron Period: An Exploratory Longitudinal Study
por: Kobuchi, Taketsune, et al.
Publicado: (2023)

Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series
por: Koba, Hayato, et al.
Publicado: (2020)

Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 2019
por: Kumar, Pramod, et al.
Publicado: (2021)

Use of Favipiravir for the Treatment of Coronavirus Disease 2019 in the Setting of Hospitel
por: Surapat, Bhitta, et al.
Publicado: (2022)

Sitafloxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide-stimulated THP-1 cells
por: Sakamaki, Ippei, et al.
Publicado: (2021)

Infection rate among close contacts of patients with coronavirus disease in Japan: a descriptive study and literature review
por: Yamamura, Osamu, et al.
Publicado: (2023)

Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population
por: Ueno, Akitoshi, et al.
Publicado: (2021)

Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019
por: Hase, Ryota, et al.
Publicado: (2020)

The effect of favipiravir on QTc interval in patients hospitalized with coronavirus disease 2019
por: Çap, Murat, et al.
Publicado: (2020)

Favipiravir-induced fever in coronavirus disease 2019: A report of two cases
por: Takoi, Hiroyuki, et al.
Publicado: (2020)

Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
por: Srinivasan, Kritika, et al.
Publicado: (2021)

Aseptic Meningitis after Amenamevir Treatment for Herpes Zoster in the First Branch of the Trigeminal Nerve
por: Itoh, Kazuhiro, et al.
Publicado: (2022)

Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study
por: Alattar, Rand A., et al.
Publicado: (2022)

Favipiravir-based regimen for coronavirus disease 2019 pneumonia for a 47-day-old male newborn
por: Moolasart, Visal, et al.
Publicado: (2020)

508. Title Favipiravir for the Treatment of Coronavirus Disease 2019; A Propensity Score Matched Cohort Study
por: Alattar, Rand A, et al.
Publicado: (2021)

Favipiravir in Therapy of Viral Infections
por: Łagocka, Ryta, et al.
Publicado: (2021)

The outcomes of favipiravir exposure in pregnancy: a case series
por: Ertem, Ozge, et al.
Publicado: (2022)

Serial computed tomography findings of Coronavirus disease 2019 (COVID-19) pneumonia treated with favipiravir and steroid therapy: report of 11 cases
por: Irizato, Naoki, et al.
Publicado: (2021)

Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as M(Pro) inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
por: Law, Woon Yi, et al.
Publicado: (2020)

Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019
por: Koshi, Eri, et al.
Publicado: (2020)

Minocycline Induces Autophagy and Inhibits Cell Proliferation in LPS-Stimulated THP-1 Cells
por: Sun, Jian, et al.
Publicado: (2020)

Retraction Note to: Efficacy of favipiravir in COVID‑19 treatment: a multi‑center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021)

Evaluation of the Effects of Favipiravir Combined with Vitamin C on Alveolar Bone in Rats
por: Lektemur Alpan, A., et al.
Publicado: (2022)

Potential Use of Iron-Limiting Therapy against Cryptococcus neoformans and Effects of Caspofungin on the Host Immune System
por: Itoh, Kazuhiro, et al.
Publicado: (2022)

Incubation period of the coronavirus disease 2019 (COVID-19) in Busan, South Korea
por: Lee, Hansol, et al.
Publicado: (2020)

Minocycline-associated vasculitis of extracranial branches of vertebral arteries presenting as myelopathy
por: Garg, Neha, et al.
Publicado: (2014)

Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure
por: Shindo, Yuichiro, et al.
Publicado: (2021)

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Dabbous, Hany M., et al.
Publicado: (2021)

Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series
por: Doi, Kent, et al.
Publicado: (2020)

Erratum to: Evaluation of the Effects of Favipiravir Combined with Vitamin C on Alveolar Bone in Rats
por: Alpan, A. Lektemur, et al.
Publicado: (2022)

A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test
por: Murai, Yushi, et al.
Publicado: (2021)

Investigation of nasopharyngeal viral load at discharge in patients with COVID-19
por: Fukui, Yasutaka, et al.
Publicado: (2021)

Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)?()
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Evaluation of risk factors for uric acid elevation in COVID-19 patients treated with favipiravir
por: Hanai, Yuki, et al.
Publicado: (2022)

Evaluation of the effect of favipiravir on patients with COVID-19
por: Kamali, Alireza, et al.
Publicado: (2023)

Successful Treatment of Cutaneous Botryomycosis with a Combination of Minocycline and Topical Heat Therapy
por: Ishibashi, Masaya, et al.
Publicado: (2012)

Generalized Granuloma Annulare Treated with Monthly Rifampicin, Ofloxacin, and Minocycline Combination Therapy
por: Garg, Shilpa, et al.
Publicado: (2013)

Multifaceted efficacy of caspofungin against fungal infections in COVID-19 patients
por: Itoh, Kazuhiro, et al.
Publicado: (2022)

Antibody level dynamics until after the third dose of COVID-19 vaccination
por: Asahi, Nanae, et al.
Publicado: (2023)

Experience of 101 patients with coronavirus infectious disease 2019 (COVID-19) at a tertiary care center in Japan
por: Yao, Kenta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t595s9htffosfqh31oddu07dj1